Clinical trials in Brazilian journals of ophthalmology: where we are

被引:1
|
作者
Cavalcanti Lira, Rodrigo Pessoa [1 ]
Leal, Franz Schubert [1 ]
Goncalves, Fauze Abdulmassih [1 ]
Ramos Amorim, Fernando Henrique [1 ]
Fernandes Felix, Joao Paulo [1 ]
Leite Arieta, Carlos Eduardo [1 ]
机构
[1] Univ Estadual Campinas, Fac Ciencias Med, UNICAMP, Campinas, SP, Brazil
关键词
Clinical trial; Ophthalmology; Citation databases; Journal Impact factor; Quality control; VISION-RELATED FUNCTION; DRY EYE DISEASE; INTRAOCULAR-LENS; CONTRAST SENSITIVITY; VISUAL-ACUITY; QUALITY; IMPACT; 0.05-PERCENT; RANIBIZUMAB; CITATION;
D O I
10.1590/S0004-27492013000100007
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare clinical trials published in Brazilian journals of ophthalmology and in foreign journals of ophthalmology with respect to the number of citations and the quality of reporting [by applying the Consolidated Standards for Reporting Trials (CONSORT) statement writing standards]. Methods: The sample of this systematic review comprised the two Brazilian journals of ophthalmology indexed at Science Citation Index Expanded and six of the foreign journals of ophthalmology with highest Impact Factor (R) according ISI. All clinical trials (CTs) published from January 2009 to December 2010 at the Brazilians journals and a 1:1 randomized sample of the foreign journals were included. The primary outcome was the number of citations through the end of 2011. Subgroup analysis included language. The secondary outcome included likelihood of citation (cited at least once versus no citation), and presence or absence of CONSORT statement indicators. Results: The citation counts were statistically significantly higher (P<0.001) in the Foreign Group (10.50) compared with the Brazilian Group (0.45). The likelihood citation was statistically significantly higher (P<0.001) in the Foreign Group (20/20 - 100%) compared with the Brazilian Group (8/20 - 40%). The subgroup analysis of the language influence in Brazilian articles showed that the citation counts were statistically significantly higher in the papers published in English (P<0.04). Of 37 possible CONSORT items, the mean for the Foreign Group was 20.55 and for the Brazilian Group was 13.65 (P<0.003). Conclusion: The number of citations and the quality of reporting of clinical trials in Brazilian journals of ophthalmology still are low when compared with the foreign journals of ophthalmology with highest Impact Factor (R).
引用
收藏
页码:21 / 25
页数:5
相关论文
共 50 条
  • [22] Endpoints for clinical trials in ophthalmology
    Schmetterer, Leopold
    Scholl, Hendrik
    Garhoefer, Gerhard
    Janeschitz-Kriegl, Lucas
    Corvi, Federico
    Sadda, Srinivas R.
    Medeiros, Felipe A.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2023, 97
  • [23] Using electronic health records for clinical trials: Where do we stand and where can we go?
    Mc Cord, Kimberly A.
    Hemkens, Lars G.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (05) : E128 - E133
  • [24] Reflections on medical oncology: 25 years of clinical trials - Where have we come and where are we going?
    Booth, Christopher M.
    Tannock, Ian
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) : 6 - 8
  • [25] Journals in professional, technical, and scientific communication: Where are we now and where are we going?
    Hayhoe, GF
    Campbell, KS
    IEEE PROFESSIONAL COMMUNICATION SOCIETY INTERNATIONAL PROFESSIONAL COMMUNICATION CONFERENCE AND ACM SPECIAL INTEREST GROUP ON DOCUMENTATION CONFERENCE, 2000, : 203 - 204
  • [26] Academic Journals on Education: where we go to ...
    Bittencourt, Agueda Bernardete
    ESPACIOS EN BLANCO-SERIE INDAGACIONES, 2015, 25 (01): : 77 - 94
  • [27] Data Sources for Evaluating Health Disparities in Ophthalmology Where We Are and Where We Need to Go
    Baxter, Sally L.
    Nwanyanwu, Kristen
    Legault, Gary
    Lee, Aaron Y.
    OPHTHALMOLOGY, 2022, 129 (10) : E146 - E149
  • [28] Are we missing out on critically appraised topics in ophthalmology journals?
    Hassanpour, Kiana
    Ahmadieh, Hamid
    JOURNAL OF CURRENT OPHTHALMOLOGY, 2021, 33 (02): : 217 - 218
  • [29] CLINICAL-TRIALS - WHERE DO WE GO FROM HERE
    CRUESS, AF
    BALLANTYNE, M
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 1992, 27 (01): : 3 - 5
  • [30] Gene therapy clinical trials, where do we go? An overview
    Arabi, Fatemeh
    Mansouri, Vahid
    Ahmadbeigi, Naser
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153